Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor
Whole genome sequencing of tumour (90X) - normal (30X) patient pair and bulk transcriptome sequencing (80M PE reads) of tumour sample.
- 2 samples
- DAC: EGAC00001001683
- Technologies: HiSeq X Ten, NextSeq 500
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001004899 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
ID | File Type | Size | Located in | |
---|---|---|---|---|
EGAF00005214253 | fastq.gz | 39.2 GB | ||
EGAF00005214254 | fastq.gz | 44.5 GB | ||
EGAF00005214255 | fastq.gz | 39.6 GB | ||
EGAF00005214256 | fastq.gz | 45.4 GB | ||
EGAF00005214257 | fastq.gz | 41.6 GB | ||
EGAF00005214258 | fastq.gz | 48.3 GB | ||
EGAF00005214259 | fastq.gz | 40.0 GB | ||
EGAF00005214260 | fastq.gz | 45.7 GB | ||
EGAF00005214261 | fastq.gz | 8.6 GB | ||
EGAF00005214262 | fastq.gz | 8.7 GB | ||
10 Files (361.5 GB) |